+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Blood Plasma Derivatives Market by Source, End User, Distribution Channel, Product Type, Application - Global Forecast to 2030- Product Image
Blood Plasma Derivatives Market by Source, End User, Distribution Channel, Product Type, Application - Global Forecast to 2030- Product Image
Sale

Blood Plasma Derivatives Market by Source, End User, Distribution Channel, Product Type, Application - Global Forecast to 2030

  • PDF Icon

    Report

  • 197 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 6010980
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The blood plasma derivatives market is evolving in response to clinical demand, advancing therapeutics, and shifts in global healthcare delivery. Senior executives navigating this sector require a cohesive, data-driven overview of strategic inflection points shaping market momentum, competitive actions, and regulatory headwinds.

Market Snapshot: Blood Plasma Derivatives Market Outlook

The Blood Plasma Derivatives Market grew from USD 523.83 million in 2024 to USD 576.03 million in 2025 and is projected to sustain a CAGR of 9.88%, reaching USD 922.24 million by 2030. Growth in this market is fueled by intensifying clinical demand for therapies serving hemophilia, immunodeficiency, and neurological disorders. The segment is further shaped by technological innovations—including recombinant therapies—and evolving regulatory and supply chain frameworks that influence product access and competitive positioning.

Scope & Segmentation Across the Blood Plasma Derivatives Ecosystem

  • Source Types: Encompasses plasma-derived products and recombinant therapies, inclusive of Factor IX and Factor VIII variants.
  • End Users: Includes hemophilia treatment centers, home care providers, and hospitals with varying needs for specialty therapies and support programs.
  • Distribution Channels: Covers hospital pharmacies, online pharmacy models, retail pharmacies, and specialist clinics offering diverse access points and patient engagement solutions.
  • Product Portfolio: Spans albumin, a range of coagulation factors (such as Factor IX, Factor VIII, fibrin sealants), and immunoglobulins (hyperimmune, intravenous, and subcutaneous forms).
  • Application Segments: Addresses hemophilia treatment, management of neurological disorders, and solutions for primary immunodeficiency.
  • Regional Coverage: Reviews markets across the Americas, Europe, Middle East & Africa, and Asia-Pacific with detailed national and sub-national analyses.
  • Company Analysis: Profiles key players such as CSL Limited, Grifols, Takeda, Octapharma, Kedrion, Biotest, LFB, Bio Products Laboratory, Shanghai RAAS Blood Products, and China Biologic Products Holdings.

Key Takeaways: Strategic Insights for Decision-Makers

  • Recombinant therapies are gaining ground as reliable alternatives to donor plasma, reducing supply volatility and enabling consistent treatment protocols.
  • Digital transformation is expanding through online pharmacies and advanced traceability measures, improving logistics and patient service models in the blood plasma derivatives market.
  • Investment in regional plasma collection and local manufacturing is on the rise, particularly in Asia-Pacific and the Middle East, aligning product offerings with local clinical and regulatory needs.
  • Collaboration via licensing agreements and partnerships with specialty healthcare and academic centers is boosting product innovation and clinical evidence generation.
  • Shifts in healthcare budgeting and payer models are requiring manufacturers to emphasize real-world evidence and economic value to maintain product access and reimbursement.
  • Niche and high-value product categories, such as subcutaneous immunoglobulins and advanced factor therapies, present targeted growth opportunities for established and emerging players alike.

Tariff Impact: Navigating U.S. Tariff Shifts in 2025

Forthcoming U.S. tariffs are pressing manufacturers to reassess sourcing and localization strategies, reshaping both cost structures and pricing negotiations. This climate has led global firms to invest in North American manufacturing expansion and prompted downstream stakeholders to pivot operational strategies amidst reimbursement uncertainty and evolving regulatory landscapes.

Methodology & Data Sources

This report is built on a rigorous research framework combining primary interviews with key opinion leaders, supply chain specialists, and C-suite executives. Findings are validated with targeted clinician and patient group surveys. Secondary research utilizes peer-reviewed literature, regulatory filings, and industry disclosures, ensuring comprehensive triangulation and reliable market intelligence.

Why This Report Matters

  • Enables executive teams to anticipate regulatory and supply chain shifts, fostering strategic agility and resilient investment planning.
  • Delivers a granular understanding of regional, application, and distribution channel nuances crucial for prioritizing portfolio innovation and market entry.
  • Offers actionable guidance to navigate competitive threats, emerging technologies, and evolving payer and patient-provider dynamics.

Conclusion

This concise executive overview distills the prevailing dynamics, risks, and opportunities in the blood plasma derivatives market. Rely on these structured and validated insights to inform your next phase of strategic decision-making.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Blood Plasma Derivatives Market, by Source
8.1. Introduction
8.2. Plasma Derived
8.3. Recombinant
8.3.1. Factor IX
8.3.2. Factor VIII
9. Blood Plasma Derivatives Market, by End User
9.1. Introduction
9.2. Hemophilia Treatment Centers
9.3. Home Care
9.4. Hospitals
10. Blood Plasma Derivatives Market, by Distribution Channel
10.1. Introduction
10.2. Hospital Pharmacy
10.3. Online Pharmacies
10.4. Retail Pharmacy
10.5. Specialist Clinics
11. Blood Plasma Derivatives Market, by Product Type
11.1. Introduction
11.2. Albumin
11.3. Coagulation Factor
11.3.1. Factor IX
11.3.2. Factor VIII
11.3.3. Fibrin Sealant
11.4. Immunoglobulin
11.4.1. Hyperimmune
11.4.2. Intravenous
11.4.3. Subcutaneous
12. Blood Plasma Derivatives Market, by Application
12.1. Introduction
12.2. Hemophilia Treatment
12.3. Neurological Disorders
12.4. Primary Immunodeficiency
13. Americas Blood Plasma Derivatives Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Blood Plasma Derivatives Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Blood Plasma Derivatives Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. CSL Limited
16.3.2. Grifols, S.A.
16.3.3. Takeda Pharmaceutical Company Limited
16.3.4. Octapharma AG
16.3.5. Kedrion S.p.A.
16.3.6. Biotest AG
16.3.7. LFB S.A.
16.3.8. Bio Products Laboratory Limited
16.3.9. Shanghai RAAS Blood Products Co., Ltd.
16.3.10. China Biologic Products Holdings, Inc.
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. BLOOD PLASMA DERIVATIVES MARKET MULTI-CURRENCY
FIGURE 2. BLOOD PLASMA DERIVATIVES MARKET MULTI-LANGUAGE
FIGURE 3. BLOOD PLASMA DERIVATIVES MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL BLOOD PLASMA DERIVATIVES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL BLOOD PLASMA DERIVATIVES MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL BLOOD PLASMA DERIVATIVES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL BLOOD PLASMA DERIVATIVES MARKET SIZE, BY SOURCE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL BLOOD PLASMA DERIVATIVES MARKET SIZE, BY SOURCE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL BLOOD PLASMA DERIVATIVES MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 10. GLOBAL BLOOD PLASMA DERIVATIVES MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL BLOOD PLASMA DERIVATIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 12. GLOBAL BLOOD PLASMA DERIVATIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL BLOOD PLASMA DERIVATIVES MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 14. GLOBAL BLOOD PLASMA DERIVATIVES MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL BLOOD PLASMA DERIVATIVES MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 16. GLOBAL BLOOD PLASMA DERIVATIVES MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS BLOOD PLASMA DERIVATIVES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. AMERICAS BLOOD PLASMA DERIVATIVES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES BLOOD PLASMA DERIVATIVES MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 20. UNITED STATES BLOOD PLASMA DERIVATIVES MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA BLOOD PLASMA DERIVATIVES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA BLOOD PLASMA DERIVATIVES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC BLOOD PLASMA DERIVATIVES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC BLOOD PLASMA DERIVATIVES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. BLOOD PLASMA DERIVATIVES MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 26. BLOOD PLASMA DERIVATIVES MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. BLOOD PLASMA DERIVATIVES MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL BLOOD PLASMA DERIVATIVES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL BLOOD PLASMA DERIVATIVES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL BLOOD PLASMA DERIVATIVES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL BLOOD PLASMA DERIVATIVES MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL BLOOD PLASMA DERIVATIVES MARKET SIZE, BY PLASMA DERIVED, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL BLOOD PLASMA DERIVATIVES MARKET SIZE, BY RECOMBINANT, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL BLOOD PLASMA DERIVATIVES MARKET SIZE, BY FACTOR IX, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL BLOOD PLASMA DERIVATIVES MARKET SIZE, BY FACTOR VIII, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL BLOOD PLASMA DERIVATIVES MARKET SIZE, BY RECOMBINANT, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL BLOOD PLASMA DERIVATIVES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL BLOOD PLASMA DERIVATIVES MARKET SIZE, BY HEMOPHILIA TREATMENT CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL BLOOD PLASMA DERIVATIVES MARKET SIZE, BY HOME CARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL BLOOD PLASMA DERIVATIVES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL BLOOD PLASMA DERIVATIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL BLOOD PLASMA DERIVATIVES MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL BLOOD PLASMA DERIVATIVES MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL BLOOD PLASMA DERIVATIVES MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL BLOOD PLASMA DERIVATIVES MARKET SIZE, BY SPECIALIST CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL BLOOD PLASMA DERIVATIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL BLOOD PLASMA DERIVATIVES MARKET SIZE, BY ALBUMIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL BLOOD PLASMA DERIVATIVES MARKET SIZE, BY COAGULATION FACTOR, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL BLOOD PLASMA DERIVATIVES MARKET SIZE, BY FACTOR IX, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL BLOOD PLASMA DERIVATIVES MARKET SIZE, BY FACTOR VIII, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL BLOOD PLASMA DERIVATIVES MARKET SIZE, BY FIBRIN SEALANT, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL BLOOD PLASMA DERIVATIVES MARKET SIZE, BY COAGULATION FACTOR, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL BLOOD PLASMA DERIVATIVES MARKET SIZE, BY IMMUNOGLOBULIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL BLOOD PLASMA DERIVATIVES MARKET SIZE, BY HYPERIMMUNE, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL BLOOD PLASMA DERIVATIVES MARKET SIZE, BY INTRAVENOUS, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL BLOOD PLASMA DERIVATIVES MARKET SIZE, BY SUBCUTANEOUS, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL BLOOD PLASMA DERIVATIVES MARKET SIZE, BY IMMUNOGLOBULIN, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL BLOOD PLASMA DERIVATIVES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL BLOOD PLASMA DERIVATIVES MARKET SIZE, BY HEMOPHILIA TREATMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL BLOOD PLASMA DERIVATIVES MARKET SIZE, BY NEUROLOGICAL DISORDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL BLOOD PLASMA DERIVATIVES MARKET SIZE, BY PRIMARY IMMUNODEFICIENCY, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. AMERICAS BLOOD PLASMA DERIVATIVES MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 38. AMERICAS BLOOD PLASMA DERIVATIVES MARKET SIZE, BY RECOMBINANT, 2018-2030 (USD MILLION)
TABLE 39. AMERICAS BLOOD PLASMA DERIVATIVES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 40. AMERICAS BLOOD PLASMA DERIVATIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 41. AMERICAS BLOOD PLASMA DERIVATIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 42. AMERICAS BLOOD PLASMA DERIVATIVES MARKET SIZE, BY COAGULATION FACTOR, 2018-2030 (USD MILLION)
TABLE 43. AMERICAS BLOOD PLASMA DERIVATIVES MARKET SIZE, BY IMMUNOGLOBULIN, 2018-2030 (USD MILLION)
TABLE 44. AMERICAS BLOOD PLASMA DERIVATIVES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 45. AMERICAS BLOOD PLASMA DERIVATIVES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 46. UNITED STATES BLOOD PLASMA DERIVATIVES MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 47. UNITED STATES BLOOD PLASMA DERIVATIVES MARKET SIZE, BY RECOMBINANT, 2018-2030 (USD MILLION)
TABLE 48. UNITED STATES BLOOD PLASMA DERIVATIVES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 49. UNITED STATES BLOOD PLASMA DERIVATIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 50. UNITED STATES BLOOD PLASMA DERIVATIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 51. UNITED STATES BLOOD PLASMA DERIVATIVES MARKET SIZE, BY COAGULATION FACTOR, 2018-2030 (USD MILLION)
TABLE 52. UNITED STATES BLOOD PLASMA DERIVATIVES MARKET SIZE, BY IMMUNOGLOBULIN, 2018-2030 (USD MILLION)
TABLE 53. UNITED STATES BLOOD PLASMA DERIVATIVES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 54. UNITED STATES BLOOD PLASMA DERIVATIVES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 55. CANADA BLOOD PLASMA DERIVATIVES MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 56. CANADA BLOOD PLASMA DERIVATIVES MARKET SIZE, BY RECOMBINANT, 2018-2030 (USD MILLION)
TABLE 57. CANADA BLOOD PLASMA DERIVATIVES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 58. CANADA BLOOD PLASMA DERIVATIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 59. CANADA BLOOD PLASMA DERIVATIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 60. CANADA BLOOD PLASMA DERIVATIVES MARKET SIZE, BY COAGULATION FACTOR, 2018-2030 (USD MILLION)
TABLE 61. CANADA BLOOD PLASMA DERIVATIVES MARKET SIZE, BY IMMUNOGLOBULIN, 2018-2030 (USD MILLION)
TABLE 62. CANADA BLOOD PLASMA DERIVATIVES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 63. MEXICO BLOOD PLASMA DERIVATIVES MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 64. MEXICO BLOOD PLASMA DERIVATIVES MARKET SIZE, BY RECOMBINANT, 2018-2030 (USD MILLION)
TABLE 65. MEXICO BLOOD PLASMA DERIVATIVES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 66. MEXICO BLOOD PLASMA DERIVATIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 67. MEXICO BLOOD PLASMA DERIVATIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 68. MEXICO BLOOD PLASMA DERIVATIVES MARKET SIZE, BY COAGULATION FACTOR, 2018-2030 (USD MILLION)
TABLE 69. MEXICO BLOOD PLASMA DERIVATIVES MARKET SIZE, BY IMMUNOGLOBULIN, 2018-2030 (USD MILLION)
TABLE 70. MEXICO BLOOD PLASMA DERIVATIVES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 71. BRAZIL BLOOD PLASMA DERIVATIVES MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 72. BRAZIL BLOOD PLASMA DERIVATIVES MARKET SIZE, BY RECOMBINANT, 2018-2030 (USD MILLION)
TABLE 73. BRAZIL BLOOD PLASMA DERIVATIVES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 74. BRAZIL BLOOD PLASMA DERIVATIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 75. BRAZIL BLOOD PLASMA DERIVATIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 76. BRAZIL BLOOD PLASMA DERIVATIVES MARKET SIZE, BY COAGULATION FACTOR, 2018-2030 (USD MILLION)
TABLE 77. BRAZIL BLOOD PLASMA DERIVATIVES MARKET SIZE, BY IMMUNOGLOBULIN, 2018-2030 (USD MILLION)
TABLE 78. BRAZIL BLOOD PLASMA DERIVATIVES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 79. ARGENTINA BLOOD PLASMA DERIVATIVES MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 80. ARGENTINA BLOOD PLASMA DERIVATIVES MARKET SIZE, BY RECOMBINANT, 2018-2030 (USD MILLION)
TABLE 81. ARGENTINA BLOOD PLASMA DERIVATIVES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 82. ARGENTINA BLOOD PLASMA DERIVATIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 83. ARGENTINA BLOOD PLASMA DERIVATIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 84. ARGENTINA BLOOD PLASMA DERIVATIVES MARKET SIZE, BY COAGULATION FACTOR, 2018-2030 (USD MILLION)
TABLE 85. ARGENTINA BLOOD PLASMA DERIVATIVES MARKET SIZE, BY IMMUNOGLOBULIN, 2018-2030 (USD MILLION)
TABLE 86. ARGENTINA BLOOD PLASMA DERIVATIVES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 87. EUROPE, MIDDLE EAST & AFRICA BLOOD PLASMA DERIVATIVES MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 88. EUROPE, MIDDLE EAST & AFRICA BLOOD PLASMA DERIVATIVES MARKET SIZE, BY RECOMBINANT, 2018-2030 (USD MILLION)
TABLE 89. EUROPE, MIDDLE EAST & AFRICA BLOOD PLASMA DERIVATIVES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 90. EUROPE, MIDDLE EAST & AFRICA BLOOD PLASMA DERIVATIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 91. EUROPE, MIDDLE EAST & AFRICA BLOOD PLASMA DERIVATIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 92. EUROPE, MIDDLE EAST & AFRICA BLOOD PLASMA DERIVATIVES MARKET SIZE, BY COAGULATION FACTOR, 2018-2030 (USD MILLION)
TABLE 93. EUROPE, MIDDLE EAST & AFRICA BLOOD PLASMA DERIVATIVES MARKET SIZE, BY IMMUNOGLOBULIN, 2018-2030 (USD MILLION)
TABLE 94. EUROPE, MIDDLE EAST & AFRICA BLOOD PLASMA DERIVATIVES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 95. EUROPE, MIDDLE EAST & AFRICA BLOOD PLASMA DERIVATIVES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 96. UNITED KINGDOM BLOOD PLASMA DERIVATIVES MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 97. UNITED KINGDOM BLOOD PLASMA DERIVATIVES MARKET SIZE, BY RECOMBINANT, 2018-2030 (USD MILLION)
TABLE 98. UNITED KINGDOM BLOOD PLASMA DERIVATIVES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 99. UNITED KINGDOM BLOOD PLASMA DERIVATIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 100. UNITED KINGDOM BLOOD PLASMA DERIVATIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 101. UNITED KINGDOM BLOOD PLASMA DERIVATIVES MARKET SIZE, BY COAGULATION FACTOR, 2018-2030 (USD MILLION)
TABLE 102. UNITED KINGDOM BLOOD PLASMA DERIVATIVES MARKET SIZE, BY IMMUNOGLOBULIN, 2018-2030 (USD MILLION)
TABLE 103. UNITED KINGDOM BLOOD PLASMA DERIVATIVES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 104. GERMANY BLOOD PLASMA DERIVATIVES MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 105. GERMANY BLOOD PLASMA DERIVATIVES MARKET SIZE, BY RECOMBINANT, 2018-2030 (USD MILLION)
TABLE 106. GERMANY BLOOD PLASMA DERIVATIVES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 107. GERMANY BLOOD PLASMA DERIVATIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 108. GERMANY BLOOD PLASMA DERIVATIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 109. GERMANY BLOOD PLASMA DERIVATIVES MARKET SIZE, BY COAGULATION FACTOR, 2018-2030 (USD MILLION)
TABLE 110. GERMANY BLOOD PLASMA DERIVATIVES MARKET SIZE, BY IMMUNOGLOBULIN, 2018-2030 (USD MILLION)
TABLE 111. GERMANY BLOOD PLASMA DERIVATIVES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 112. FRANCE BLOOD PLASMA DERIVATIVES MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 113. FRANCE BLOOD PLASMA DERIVATIVES MARKET SIZE, BY RECOMBINANT, 2018-2030 (USD MILLION)
TABLE 114. FRANCE BLOOD PLASMA DERIVATIVES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 115. FRANCE BLOOD PLASMA DERIVATIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 116. FRANCE BLOOD PLASMA DERIVATIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 117. FRANCE BLOOD PLASMA DERIVATIVES MARKET SIZE, BY COAGULATION FACTOR, 2018-2030 (USD MILLION)
TABLE 118. FRANCE BLOOD PLASMA DERIVATIVES MARKET SIZE, BY IMMUNOGLOBULIN, 2018-2030 (USD MILLION)
TABLE 119. FRANCE BLOOD PLASMA DERIVATIVES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 120. RUSSIA BLOOD PLASMA DERIVATIVES MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 121. RUSSIA BLOOD PLASMA DERIVATIVES MARKET SIZE, BY RECOMBINANT, 2018-2030 (USD MILLION)
TABLE 122. RUSSIA BLOOD PLASMA DERIVATIVES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 123. RUSSIA BLOOD PLASMA DERIVATIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 124. RUSSIA BLOOD PLASMA DERIVATIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 125. RUSSIA BLOOD PLASMA DERIVATIVES MARKET SIZE, BY COAGULATION FACTOR, 2018-2030 (USD MILLION)
TABLE 126. RUSSIA BLOOD PLASMA DERIVATIVES MARKET SIZE, BY IMMUNOGLOBULIN, 2018-2030 (USD MILLION)
TABLE 127. RUSSIA BLOOD PLASMA DERIVATIVES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 128. ITALY BLOOD PLASMA DERIVATIVES MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 129. ITALY BLOOD PLASMA DERIVATIVES MARKET SIZE, BY RECOMBINANT, 2018-2030 (USD MILLION)
TABLE 130. ITALY BLOOD PLASMA DERIVATIVES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 131. ITALY BLOOD PLASMA DERIVATIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 132. ITALY BLOOD PLASMA DERIVATIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 133. ITALY BLOOD PLASMA DERIVATIVES MARKET SIZE, BY COAGULATION FACTOR, 2018-2030 (USD MILLION)
TABLE 134. ITALY BLOOD PLASMA DERIVATIVES MARKET SIZE, BY IMMUNOGLOBULIN, 2018-2030 (USD MILLION)
TABLE 135. ITALY BLOOD PLASMA DERIVATIVES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 136. SPAIN BLOOD PLASMA DERIVATIVES MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 137. SPAIN BLOOD PLASMA DERIVATIVES MARKET SIZE, BY RECOMBINANT, 2018-2030 (USD MILLION)
TABLE 138. SPAIN BLOOD PLASMA DERIVATIVES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 139. SPAIN BLOOD PLASMA DERIVATIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 140. SPAIN BLOOD PLASMA DERIVATIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 141. SPAIN BLOOD PLASMA DERIVATIVES MARKET SIZE, BY COAGULATION FACTOR, 2018-2030 (USD MILLION)
TABLE 142. SPAIN BLOOD PLASMA DERIVATIVES MARKET SIZE, BY IMMUNOGLOBULIN, 2018-2030 (USD MILLION)
TABLE 143. SPAIN BLOOD PLASMA DERIVATIVES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 144. UNITED ARAB EMIRATES BLOOD PLASMA DERIVATIVES MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 145. UNITED ARAB EMIRATES BLOOD PLASMA DERIVATIVES MARKET SIZE, BY RECOMBINANT, 2018-2030 (USD MILLION)
TABLE 146. UNITED ARAB EMIRATES BLOOD PLASMA DERIVATIVES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 147. UNITED ARAB EMIRATES BLOOD PLASMA DERIVATIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 148. UNITED ARAB EMIRATES BLOOD PLASMA DERIVATIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 149. UNITED ARAB EMIRATES BLOOD PLASMA DERIVATIVES MARKET SIZE, BY COAGULATION FACTOR, 2018-2030 (USD MILLION)
TABLE 150. UNITED ARAB EMIRATES BLOOD PLASMA DERIVATIVES MARKET SIZE, BY IMMUNOGLOBULIN, 2018-2030 (USD MILLION)
TABLE 151. UNITED ARAB EMIRATES BLOOD PLASMA DERIVATIVES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 152. SAUDI ARABIA BLOOD PLASMA DERIVATIVES MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 153. SAUDI ARABIA BLOOD PLASMA DERIVATIVES MARKET SIZE, BY RECOMBINANT, 2018-2030 (USD MILLION)
TABLE 154. SAUDI ARABIA BLOOD PLASMA DERIVATIVES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 155. SAUDI ARABIA BLOOD PLASMA DERIVATIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 156. SAUDI ARABIA BLOOD PLASMA DERIVATIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 157. SAUDI ARABIA BLOOD PLASMA DERIVATIVES MARKET SIZE, BY COAGULATION FACTOR, 2018-2030 (USD MILLION)
TABLE 158. SAUDI ARABIA BLOOD PLASMA DERIVATIVES MARKET SIZE, BY IMMUNOGLOBULIN, 2018-2030 (USD MILLION)
TABLE 159. SAUDI ARABIA BLOOD PLASMA DERIVATIVES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 160. SOUTH AFRICA BLOOD PLASMA DERIVATIVES MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 161. SOUTH AFRICA BLOOD PLASMA DERIVATIVES MARKET SIZE, BY RECOMBINANT, 2018-2030 (USD MILLION)
TABLE 162. SOUTH AFRICA BLOOD PLASMA DERIVATIVES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 163. SOUTH AFRICA BLOOD PLASMA DERIVATIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 164. SOUTH AFRICA BLOOD PLASMA DERIVATIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 165. SOUTH AFRICA BLOOD PLASMA DERIVATIVES MARKET SIZE, BY COAGULATION FACTOR, 2018-2030 (USD MILLION)
TABLE 166. SOUTH AFRICA BLOOD PLASMA DERIVATIVES MARKET SIZE, BY IMMUNOGLOBULIN, 2018-2030 (USD MILLION)
TABLE 167. SOUTH AFRICA BLOOD PLASMA DERIVATIVES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 168. DENMARK BLOOD PLASMA DERIVATIVES MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 169. DENMARK BLOOD PLASMA DERIVATIVES MARKET SIZE, BY RECOMBINANT, 2018-2030 (USD MILLION)
TABLE 170. DENMARK BLOOD PLASMA DERIVATIVES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 171. DENMARK BLOOD PLASMA DERIVATIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 172. DENMARK BLOOD PLASMA DERIVATIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 173. DENMARK BLOOD PLASMA DERIVATIVES MARKET SIZE, BY COAGULATION FACTOR, 2018-2030 (USD MILLION)
TABLE 174. DENMARK BLOOD PLASMA DERIVATIVES MARKET SIZE, BY IMMUNOGLOBULIN, 2018-2030 (USD MILLION)
TABLE 175. DENMARK BLOOD PLASMA DERIVATIVES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 176. NETHERLANDS BLOOD PLASMA DERIVATIVES MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 177. NETHERLANDS BLOOD PLASMA DERIVATIVES MARKET SIZE, BY RECOMBINANT, 2018-2030 (USD MILLION)
TABLE 178. NETHERLANDS BLOOD PLASMA DERIVATIVES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 179. NETHERLANDS BLOOD PLASMA DERIVATIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 180. NETHERLANDS BLOOD PLASMA DERIVATIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 181. NETHERLANDS BLOOD PLASMA DERIVATIVES MARKET SIZE, BY COAGULATION FACTOR, 2018-2030 (USD MILLION)
TABLE 182. NETHERLANDS BLOOD PLASMA DERIVATIVES MARKET SIZE, BY IMMUNOGLOBULIN, 2018-2030 (USD MILLION)
TABLE 183. NETHERLANDS BLOOD PLASMA DERIVATIVES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 184. QATAR BLOOD PLASMA DERIVATIVES MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 185. QATAR BLOOD PLASMA DERIVATIVES MARKET SIZE, BY RECOMBINANT, 2018-2030 (USD MILLION)
TABLE 186. QATAR BLOOD PLASMA DERIVATIVES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 187. QATAR BLOOD PLASMA DERIVATIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 188. QATAR BLOOD PLASMA DERIVATIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 189. QATAR BLOOD PLASMA DERIVATIVES MARKET SIZE, BY COAGULATION FACTOR, 2018-2030 (USD MILLION)
TABLE 190. QATAR BLOOD PLASMA DERIVATIVES MARKET SIZE, BY IMMUNOGLOBULIN, 2018-2030 (USD MILLION)
TABLE 191. QATAR BLOOD PLASMA DERIVATIVES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 192. FINLAND BLOOD PLASMA DERIVATIVES MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 193. FINLAND BLOOD PLASMA DERIVATIVES MARKET SIZE, BY RECOMBINANT, 2018-2030 (USD MILLION)
TABLE 194. FINLAND BLOOD PLASMA DERIVATIVES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 195. FINLAND BLOOD PLASMA DERIVATIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 196. FINLAND BLOOD PLASMA DERIVATIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 197. FINLAND BLOOD PLASMA DERIVATIVES MARKET SIZE, BY COAGULATION FACTOR, 2018-2030 (USD MILLION)
TABLE 198. FINLAND BLOOD PLASMA DERIVATIVES MARKET SIZE, BY IMMUNOGLOBULIN, 2018-2030 (USD MILLION)
TABLE 199. FINLAND BLOOD PLASMA DERIVATIVES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 200. SWEDEN BLOOD PLASMA DERIVATIVES MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 201. SWEDEN BLOOD PLASMA DERIVATIVES MARKET SIZE, BY RECOMBINANT, 2018-2030 (USD MILLION)
TABLE 202. SWEDEN BLOOD PLASMA DERIVATIVES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 203. SWEDEN BLOOD PLASMA DERIVATIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 204. SWEDEN BLOOD PLASMA DERIVATIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 205. SWEDEN BLOOD PLASMA DERIVATIVES MARKET SIZE, BY COAGULATION FACTOR, 2018-2030 (USD MILLION)
TABLE 206. SWEDEN BLOOD PLASMA DERIVATIVES MARKET SIZE, BY IMMUNOGLOBULIN, 2018-2030 (USD MILLION)
TABLE 207. SWEDEN BLOOD PLASMA DERIVATIVES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 208. NIGERIA BLOOD PLASMA DERIVATIVES MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 209. NIGERIA BLOOD PLASMA DERIVATIVES MARKET SIZE, BY RECOMBINANT, 2018-2030 (USD MILLION)
TABLE 210. NIGERIA BLOOD PLASMA DERIVATIVES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 211. NIGERIA BLOOD PLASMA DERIVATIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 212. NIGERIA BLOOD PLASMA DERIVATIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 213. NIGERIA BLOOD PLASMA DERIVATIVES MARKET SIZE, BY COAGULATION FACTOR, 2018-2030 (USD MILLION)
TABLE 214. NIGERIA BLOOD PLASMA DERIVATIVES MARKET SIZE, BY IMMUNOGLOBULIN, 2018-2030 (USD MILLION)
TABLE 215. NIGERIA BLOOD PLASMA DERIVATIVES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 216. EGYPT BLOOD PLASMA DERIVATIVES MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 217. EGYPT BLOOD PLASMA DERIVATIVES MARKET SIZE, BY RECOMBINANT, 2018-2030 (USD MILLION)
TABLE 218. EGYPT BLOOD PLASMA DERIVATIVES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 219. EGYPT BLOOD PLASMA DERIVATIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 220. EGYPT BLOOD PLASMA DERIVATIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 221. EGYPT BLOOD PLASMA DERIVATIVES MARKET SIZE, BY COAGULATION FACTOR, 2018-2030 (USD MILLION)
TABLE 222. EGYPT BLOOD PLASMA DERIVATIVES MARKET SIZE, BY IMMUNOGLOBULIN, 2018-2030 (USD MILLION)
TABLE 223. EGYPT BLOOD PLASMA DERIVATIVES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 224. TURKEY BLOOD PLASMA DERIVATIVES MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 225. TURKEY BLOOD PLASMA DERIVATIVES MARKET SIZE, BY RECOMBINANT, 2018-2030 (USD MILLION)
TABLE 226. TURKEY BLOOD PLASMA DERIVATIVES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 227. TURKEY BLOOD PLASMA DERIVATIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 228. TURKEY BLOOD PLASMA DERIVATIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 229. TURKEY BLOOD PLASMA DERIVATIVES MARKET SIZE, BY COAGULATION FACTOR, 2018-2030 (USD MILLION)
TABLE 230. TURKEY BLOOD PLASMA DERIVATIVES MARKET SIZE, BY IMMUNOGLOBULIN, 2018-2030 (USD MILLION)
TABLE 231. TURKEY BLOOD PLASMA DERIVATIVES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 232. ISRAEL BLOOD PLASMA DERIVATIVES MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 233. ISRAEL BLOOD PLASMA DERIVATIVES MARKET SIZE, BY RECOMBINANT, 2018-2030 (USD MILLION)
TABLE 234. ISRAEL BLOOD PLASMA DERIVATIVES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 235. ISRAEL BLOOD PLASMA DERIVATIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 236. ISRAEL BLOOD PLASMA DERIVATIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 237. ISRAEL BLOOD PLASMA DERIVATIVES MARKET SIZE, BY COAGULATION FACTOR, 2018-2030 (USD MILLION)
TABLE 238. ISRAEL BLOOD PLASMA DERIVATIVES MARKET SIZE, BY IMMUNOGLOBULIN, 2018-2030 (USD MILLION)
TABLE 239. ISRAEL BLOOD PLASMA DERIVATIVES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 240. NORWAY BLOOD PLASMA DERIVATIVES MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 241. NORWAY BLOOD PLASMA DERIVATIVES MARKET SIZE, BY RECOMBINANT, 2018-2030 (USD MILLION)
TABLE 242. NORWAY BLOOD PLASMA DERIVATIVES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 243. NORWAY BLOOD PLASMA DERIVATIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 244. NORWAY BLOOD PLASMA DERIVATIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 245. NORWAY BLOOD PLASMA DERIVATIVES MARKET SIZE, BY COAGULATION FACTOR, 2018-2030 (USD MILLION)
TABLE 246. NORWAY BLOOD PLASMA DERIVATIVES MARKET SIZE, BY IMMUNOGLOBULIN, 2018-2030 (USD MILLION)
TABLE 247. NORWAY BLOOD PLASMA DERIVATIVES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 248. POLAND BLOOD PLASMA DERIVATIVES MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 249. POLAND BLOOD PLASMA DERIVATIVES MARKET SIZE, BY RECOMBINANT, 2018-2030 (USD MILLION)
TABLE 250. POLAND BLOOD PLASMA DERIVATIVES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 251. POLAND BLOOD PLASMA DERIVATIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 252. POLAND BLOOD PLASMA DERIVATIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 253. POLAND BLOOD PLASMA DERIVATIVES MARKET SIZE, BY COAGULATION FACTOR, 2018-2030 (USD MILLION)
TABLE 254. POLAND BLOOD PLASMA DERIVATIVES MARKET SIZE, BY IMMUNOGLOBULIN, 2018-2030 (USD MILLION)
TABLE 255. POLAND BLOOD PLASMA DERIVATIVES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 256. SWITZERLAND BLOOD PLASMA DERIVATIVES MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 257. SWITZERLAND BLOOD PLASMA DERIVATIVES MARKET SIZE, BY RECOMBINANT, 2018-2030 (USD MILLION)
TABLE 258. SWITZERLAND BLOOD PLASMA DERIVATIVES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 259. SWITZERLAND BLOOD PLASMA DERIVATIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 260. SWITZERLAND BLOOD PLASMA DERIVATIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 261. SWITZERLAND BLOOD PLASMA DERIVATIVES MARKET SIZE, BY COAGULATION FACTOR, 2018-2030 (USD MILLION)
TABLE 262. SWITZERLAND BLOOD PLASMA DERIVATIVES MARKET SIZE, BY IMMUNOGLOBULIN, 2018-2030 (USD MILLION)
TABLE 263. SWITZERLAND BLOOD PLASMA DERIVATIVES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 264. ASIA-PACIFIC BLOOD PLASMA DERIVATIVES MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 265. ASIA-PACIFIC BLOOD PLASMA DERIVATIVES MARKET SIZE, BY RECOMBINANT, 2018-2030 (USD MILLION)
TABLE 266. ASIA-PACIFIC BLOOD PLASMA DERIVATIVES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 267. ASIA-PACIFIC BLOOD PLASMA DERIVATIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 268. ASIA-PACIFIC BLOOD PLASMA DERIVATIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 269. ASIA-PACIFIC BLOOD PLASMA DERIVATIVES MARKET SIZE, BY COAGULATION FACTOR, 2018-2030 (USD MILLION)
TABLE 270. ASIA-PACIFIC BLOOD PLASMA DERIVATIVES MARKET SIZE, BY IMMUNOGLOBULIN, 2018-2030 (USD MILLION)
TABLE 271. ASIA-PACIFIC BLOOD PLASMA DERIVATIVES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 272. ASIA-PACIFIC BLOOD PLASMA DERIVATIVES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 273. CHINA BLOOD PLASMA DERIVATIVES MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 274. CHINA BLOOD PLASMA DERIVATIVES MARKET SIZE, BY RECOMBINANT, 2018-2030 (USD MILLION)
TABLE 275. CHINA BLOOD PLASMA DERIVATIVES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 276. CHINA BLOOD PLASMA DERIVATIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 277. CHINA BLOOD PLASMA DERIVATIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 278. CHINA BLOOD PLASMA DERIVATIVES MARKET SIZE, BY COAGULATION FACTOR, 2018-2030 (USD MILLION)
TABLE 279. CHINA BLOOD PLASMA DERIVATIVES MARKET SIZE, BY IMMUNOGLOBULIN, 2018-2030 (USD MILLION)
TABLE 280. CHINA BLOOD PLASMA DERIVATIVES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 281. INDIA BLOOD PLASMA DERIVATIVES MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 282. INDIA BLOOD PLASMA DERIVATIVES MARKET SIZE, BY RECOMBINANT, 2018-2030 (USD MILLION)
TABLE 283. INDIA BLOOD PLASMA DERIVATIVES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 284. INDIA BLOOD PLASMA DERIVATIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 285. INDIA BLOOD PLASMA DERIVATIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 286. INDIA BLOOD PLASMA DERIVATIVES MARKET SIZE, BY COAGULATION FACTOR, 2018-2030 (USD MILLION)
TABLE 287. INDIA BLOOD PLASMA DERIVATIVES MARKET SIZE, BY IMMUNOGLOBULIN, 2018-2030 (USD MILLION)
TABLE 288. INDIA BLOOD PLASMA DERIVATIVES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 289. JAPAN BLOOD PLASMA DERIVATIVES MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 290. JAPAN BLOOD PLASMA DERIVATIVES MARKET SIZE, BY RECOMBINANT, 2018-2030 (USD MILLION)
TABLE 291. JAPAN BLOOD PLASMA DERIVATIVES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 292. JAPAN BLOOD PLASMA DERIVATIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 293. JAPAN BLOOD PLASMA DERIVATIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 294. JAPAN BLOOD PLASMA DERIVATIVES MARKET SIZE, BY COAGULATION FACTOR, 2018-2030 (USD MILLION)
TABLE 295. JAPAN BLOOD PLASMA DERIVATIVES MARKET SIZE, BY IMMUNOGLOBULIN, 2018-2030 (USD MILLION)
TABLE 296. JAPAN BLOOD PLASMA DERIVATIVES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 297. AUSTRALIA BLOOD PLASMA DERIVATIVES MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 298. AUSTRALIA BLOOD PLASMA DERIVATIVES MARKET SIZE, BY RECOMBINANT, 2018-2030 (USD MILLION)
TABLE 299. AUSTRALIA BLOOD PLASMA DERIVATIVES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 300. AUSTRALIA BLOOD PLASMA DERIVATIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 301. AUSTRALIA BLOOD PLASMA DERIVATIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 302. AUSTRALIA BLOOD PLASMA DERIVATIVES MARKET SIZE, BY COAGULATION FACTOR, 2018-2030 (USD MILLION)
TABLE 303. AUSTRALIA BLOOD PLASMA DERIVATIVES MARKET SIZE, BY IMMUNOGLOBULIN, 2018-2030 (USD MILLION)
TABLE 304. AUSTRALIA BLOOD PLASMA DERIVATIVES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 305. SOUTH KOREA BLOOD PLASMA DERIVATIVES MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 306. SOUTH KOREA BLOOD PLASMA DERIVATIVES MARKET SIZE, BY RECOMBINANT, 2018-2030 (USD MILLION)
TABLE 307. SOUTH KOREA BLOOD PLASMA DERIVATIVES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 308. SOUTH KOREA BLOOD PLASMA DERIVATIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 309. SOUTH KOREA BLOOD PLASMA DERIVATIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 310. SOUTH KOREA BLOOD PLASMA DERIVATIVES MARKET SIZE, BY COAGULATION FACTOR, 2018-2030 (USD MILLION)
TABLE 311. SOUTH KOREA BLOOD PLASMA DERIVATIVES MARKET SIZE, BY IMMUNOGLOBULIN, 2018-2030 (USD MILLION)
TABLE 312. SOUTH KOREA BLOOD PLASMA DERIVATIVES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 313. INDONESIA BLOOD PLASMA DERIVATIVES MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 314. INDONESIA BLOOD PLASMA DERIVATIVES MARKET SIZE, BY RECOMBINANT, 2018-2030 (USD MILLION)
TABLE 315. INDONESIA BLOOD PLASMA DERIVATIVES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 316. INDONESIA BLOOD PLASMA DERIVATIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 317. INDONESIA BLOOD PLASMA DERIVATIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 318. INDONESIA BLOOD PLASMA DERIVATIVES MARKET SIZE, BY COAGULATION FACTOR, 2018-2030 (USD MILLION)
TABLE 319. INDONESIA BLOOD PLASMA DERIVATIVES MARKET SIZE, BY IMMUNOGLOBULIN, 2018-2030 (USD MILLION)
TABLE 320. INDONESIA BLOOD PLASMA DERIVATIVES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 321. THAILAND BLOOD PLASMA DERIVATIVES MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 322. THAILAND BLOOD PLASMA DERIVATIVES MARKET SIZE, BY RECOMBINANT, 2018-2030 (USD MILLION)
TABLE 323. THAILAND BLOOD PLASMA DERIVATIVES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 324. THAILAND BLOOD PLASMA DERIVATIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 325. THAILAND BLOOD PLASMA DERIVATIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 326. THAILAND BLOOD PLASMA DERIVATIVES MARKET SIZE, BY COAGULATION FACTOR, 2018-2030 (USD MILLION)
TABLE 327. THAILAND BLOOD PLASMA DERIVATIVES MARKET SIZE, BY IMMUNOGLOBULIN, 2018-2030 (USD MILLION)
TABLE 328. THAILAND BLOOD PLAS

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Blood Plasma Derivatives market report include:
  • CSL Limited
  • Grifols, S.A.
  • Takeda Pharmaceutical Company Limited
  • Octapharma AG
  • Kedrion S.p.A.
  • Biotest AG
  • LFB S.A.
  • Bio Products Laboratory Limited
  • Shanghai RAAS Blood Products Co., Ltd.
  • China Biologic Products Holdings, Inc.

Table Information

Report AttributeDetails
No. of Pages197
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 576.03 Million
Forecasted Market Value ( USD ) by 2030 $ 922.24 Million
Compound Annual Growth Rate9.8%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Blood Plasma Derivatives Market Size, Share, Trends and Forecast by Type, Application, End User, and Region, 2025-2033 - Product Image

Blood Plasma Derivatives Market Size, Share, Trends and Forecast by Type, Application, End User, and Region, 2025-2033

  • Report
  • 149 Pages
  • Global
From
Blood Plasma Derivatives Market Report 2025 - Product Image

Blood Plasma Derivatives Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Bovine Blood Plasma Derivatives - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2024 - 2029) - Product Image

Bovine Blood Plasma Derivatives - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2024 - 2029)

  • Report
  • 120 Pages
  • Global
From
Blood Plasma Derivatives Global Market Insights 2025, Analysis and Forecast to 2030, by Manufacturers, Regions, Technology, Application, Product Type - Product Image

Blood Plasma Derivatives Global Market Insights 2025, Analysis and Forecast to 2030, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • 93 Pages
  • Global
From
Blood Plasma Fractionation Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F - Product Image

Blood Plasma Fractionation Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

  • Report
  • 182 Pages
  • Global
From

About the Plasma Derivative Market

The Plasma Derivative market is a subset of the Blood Banking industry, which involves the collection, processing, and distribution of human blood and its components. Plasma derivatives are products derived from human plasma, such as albumin, immunoglobulins, and clotting factors. These products are used to treat a variety of medical conditions, including hemophilia, immune deficiencies, and shock. Plasma derivatives are typically collected from healthy donors and processed in a laboratory setting. The process involves separating the plasma from the other components of the blood, such as red and white blood cells. The plasma is then further processed to create the desired product. The Plasma Derivative market is highly regulated, with stringent safety and quality standards in place to ensure the safety of the products. Companies in the market include CSL Behring, Grifols, Octapharma, Kedrion, and Biotest. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.